Granules India And Glenmark Pharma Share Prices Rallied Nearly 3 Percent

Granules India and Glenmark Pharma share prices rallied nearly 3 percent in the morning trade on January 7 on receiving approvals from the US health regulator for new drugs.

Granules India, with a market capitalisation of Rs 3,100 crore, got the US Food and Drug Administration’s nod for Acetaminophen tablet, a painkiller.

Glenmark Pharma got the clearance for Deferasirox tablets, reported CNBC-TV18. Deferasirox is used in the treatment of chronic iron overload syndrome.

For more information ✆ +91- 6232578593 or visit www.moneymarketmanthan.com